Le Lézard
Classified in: Health
Subjects: NPT, CHI, LEG, AVO, MAT

Congress Should Pass Tobacco 21 Legislation Free of Special Interest Provisions for Tobacco Companies


WASHINGTON, April 18, 2019 /PRNewswire/ -- The Campaign for Tobacco-Free Kids strongly supports effective federal legislation to raise the tobacco age to 21 nationwide and supported the bills introduced in the last Congress by Sen. Brian Schatz and Rep. Diana DeGette, which we understand will be reintroduced in the near future. We have not seen the language of the bill that Senate Majority Leader Mitch McConnell (R-KY) announced he will introduce, so we cannot comment on that specific legislation.

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

While we strongly support raising the tobacco age to 21, we are deeply concerned that tobacco companies have worked to add special interest provisions to state and federal Tobacco 21 bills that shield the industry from other regulations to protect kids and public health, such as prohibitions on flavored tobacco products. It is critical that Congress enact strong Tobacco 21 legislation that is free of special interest provisions that benefit the industry.

At the state level, tobacco companies have worked to include provisions in Tobacco 21 bills that block local regulation of tobacco products, including curbs on flavored tobacco products. Arkansas recently enacted a Tobacco 21 law with such a preemption provision, and other states are considering similar measures.

At the federal level, we also oppose the Tobacco 21 bill recently introduced by Rep. Robert Aderholt (R-AL) because it includes a provision that could benefit tobacco giants Philip Morris International and Altria at the expense of kids and public health. This provision creates a new definition of "vapor product" that would include the IQOS heated tobacco product, which Philip Morris International is currently seeking FDA authorization to market in the United States (with Altria as the U.S. distributor). If this definition is adopted broadly by the FDA, the impact would be to classify IQOS and similar products as vapor products rather than as cigarettes. This would allow IQOS to escape stronger regulations on cigarettes, such as existing prohibitions on flavors and restrictions on marketing that appeals to kids (including prohibitions on sponsorships of music, sports and other events). Classifying IQOS and similar products as vapor products rather than cigarettes would clear the way for tobacco companies to market these products using flavors and tactics that appeal to kids.

While an important step, Tobacco 21 legislation should be a complement to ? and not a substitute for ? other measures to reverse the youth e-cigarette epidemic and continue reducing youth tobacco use. It is especially critical that action be taken to prohibit the flavored products that have driven the youth e-cigarette epidemic. Until Congress or the FDA acts, states and localities should ramp up their efforts to prohibit these flavored products. That is why it is imperative for Congress and state legislatures to reject tobacco industry efforts to use Tobacco 21 as a vehicle to block effective regulations such as prohibitions on flavored products.

We also urge Congress not to exempt active military personnel from Tobacco 21 legislation as Sen. McConnell is proposing, particularly in light of the military's recognition that tobacco use harms troop readiness and health and costs the government billions in health care costs annually. The military is actively working to reduce tobacco use within its ranks, and Congress should support these efforts by passing a Tobacco 21 bill without a military exemption.

 

SOURCE Campaign for Tobacco-Free Kids


These press releases may also interest you

at 09:50
The "Targeted Sequencing Market - A Global and Regional Analysis: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Region - Analysis and Forecast, 2024-2033" report has been added to...

at 09:43
Discover new ways to make your skin BLOOM! Beekman 1802's top selling skin barrier-building formula, Bloom Cream Daily Face Moisturizer, is now available in two NEW formats that will make blooming even better! Introducing the Bloom Cream in a Tube...

at 09:00
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5374, a phase 1/2a study evaluating the safety, tolerability, and antiviral effect of a novel combination regimen that includes...

at 09:00
PureTalk, a nationwide cell phone service provider offering premium wireless service at a fair price on the nation's most dependable 5G network, today celebrates over $100,000 customer donations to the America's Warrior Partnership (AWP). Since...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 09:00
On 5 April 2024, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Board of Directors, with the support of the authorization granted by the annual general meeting held on 17 May 2023, had resolved on a rights issue of units,...



News published on and distributed by: